查看购物车
  • Traditional Chinese
  • English
  • Japanese
肠内和肠外医疗营养市场预测至2028年 - COVID-19的影响以及按适应症、营养类型、形式、产品类型、给药途径、年龄组和分销渠道的全球分析
市场调查报告书
商品编码
1296779

肠内和肠外医疗营养市场预测至2028年 - COVID-19的影响以及按适应症、营养类型、形式、产品类型、给药途径、年龄组和分销渠道的全球分析

Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Global Analysis by Indication, Nutrition Type, Form, Product Type, Route of Administration, Age Group, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 720 Pages | 订单完成后即时交付

价格

肠内和肠外医疗营养市场规模预计将从2022年的173.4亿美元增长到2028年的254.7亿美元；估计从2023年到2028年的复合增长率为6.8%。

肠内和肠外医疗营养市场的增长归因于胃肠道疾病患病率的上升以及营养不良和早产病例的增加。

对帮助消费者主动管理其健康的产品需求激增，特别是那些专注于能量水平、免疫力和疾病治疗方面的特定需求的产品。营养需求根据疾病的类型而有所不同。肠内和肠外产品的功能和特定配方不会干扰提供给病人的现有治疗，并有助于按照要求提供更精确和更多的治疗。肠内和肠外营养的宏观和微量营养素配方及其应用根据各种疾病（如癌症和胃肠道疾病）而有所不同。此外，制药公司提供的肠内和肠外营养的成分是个性化的（针对病人）。例如，Impact（由雀巢公司提供）是一种经过临床验证的营养解决方案，用于管理接受重大选择性手术的患者，以减少术后并发症和住院时间，改善临床结果。公司努力为独特需求提供此类配方，将推动肠道和肠外医疗营养市场的增长。

此外，各种组织正在努力传播对使用特定营养配方的认识。例如，美国肠外和肠内营养协会（称为ASPEN）是一个总部设在美国的医疗专业组织，它雇用了营养师、药剂师、医生和助理、护士、执业护士、科学家、学生以及其他来自各个营养领域的健康专家，为病人提供临床营养并对他们进行教育。这些因素将支持肠道和肠外医疗营养市场在未来的增长。

此外，转向植物性食物的人数激增，引发了全球对植物性营养产品的需求。人们更有可能对使用较多的人工/合成成分表现出不耐受，这可能导致不良反应。因此，成分越少，最终产品就越好。2020年Innova消费者调查显示，健康、饮食多样性、可持续性和口味是人们考虑植物性替代品的首要原因。据雅培公司称，消费者和依靠管饲的病人也不例外，他们都是这种趋势的受益者。美国医学协会正在呼吁医疗机构提出以植物为基础的膳食选择，以改善病人的健康。包括加利福尼亚州、纽约州和哥伦比亚特区在内的各州已经要求医院向所有病人提供健康的植物性膳食。肠内和肠外医疗营养市场的公司预计，对健康食品的日益关注将转化为对更健康营养产品的偏好。2021年9月，雅培公司为儿童和成人推出了植物性蛋白质和有机食品原料的产品组合。同样，基于橄榄油的肠外营养产品也越来越受欢迎。

因此，功能性、以病人为中心的配方和基于植物的营养产品是肠内和肠外医疗营养市场的主要新兴趋势。

基于年龄组的洞察力

基于年龄组，肠内和肠外医疗营养市场被分为60岁以上、18-60岁、3-18岁和3岁以下。2022年，60岁以上部分在肠内和肠外医疗营养市场中占最大份额。然而，在预测期内，18-60岁的部分预计将注册最高的复合年增长率。体重下降和营养不良在60岁以上的人中很常见。随着年龄的增长，老年人口的免疫力下降，他们变得更容易受到可能恶化他们健康的疾病。由于这个原因，医生开出了外部营养来维持免疫力和体重。根据发表在PubMed Central的几项研究，慢性病和残疾的发病率在老年人中明显更高，产生了对家庭治疗的需求。另外，根据人口资料局（2019年）的估计，美国的老年人口预计将从2018年的5200万增长到2060年的9500万。由于老年群体的残疾，对家庭护理的需求不断增加，家庭治疗的需求也随之增加。因此，老年人口基数的增加预计将促进肠道和肠外医疗营养市场的细分市场的增长。

英国肠外和肠内营养协会、美国疾病控制和预防中心（CDC）以及全球疾病负担研究是编写肠内和肠外医疗营养市场报告时参考的主要和次要资料来源。

目录

第一章：简介

  • 本研究的范围
  • Insight Partners的研究报告指导
  • 市场细分
    • 全球肠内和肠外医疗营养市场 - 按适应症分类
    • 全球肠内和肠外医疗营养市场 - 按营养类型划分
    • 全球肠内和肠外医疗营养市场 - 按形式划分
    • 全球肠内和肠外医疗营养市场 - 按产品类型划分
    • 全球肠内和肠外医疗营养品市场 - 按给药途径分类
    • 全球肠内和肠外医疗营养市场 - 按年龄组划分
    • 全球肠内和肠外医疗营养品市场 - 按销售渠道分类
    • 全球肠内和肠外医疗营养品市场 - 按地域划分

第二章：主要结论

第三章：研究方法

  • 覆盖面
  • 二级研究
  • 初级研究

第四章：肠内和肠外医疗营养市场 - 市场格局

  • 概述
  • PEST分析
    • 北美洲PEST分析
    • 欧洲PEST分析
    • 亚太地区PEST分析
    • 中东和非洲PEST分析
    • 南美和中美洲PEST分析
  • 专家意见
  • 能量含量分析
    • 低于1.5千卡/毫升
    • 相当于1.5千卡/毫升
    • 低于2千卡/毫升
    • 等于或高于2kcal/ml：

第五章：肠内和肠外医疗营养品市场-主要市场动态

  • 市场驱动力
    • 胃肠道疾病发病率的上升
    • 营养不良和早产的病例不断增加
  • 市场限制因素
    • 与肠内和肠外喂养系统相关的机械、胃肠道和代谢并发症，以及与导管放置相关的限制。
  • 市场机会
    • 公司的战略倡议不断增加
  • 未来趋势
    • 特定配方和植物性营养产品
  • 影响分析

第六章：肠内和肠外医疗营养市场 - 全球分析

  • 全球肠内和肠外医疗营养品市场收入预测和分析
    • 全球肠内和肠外医疗营养品市场，按地域划分 - 预测和分析
  • 公司分析
    • 主要企业的市场定位
  • 肠内和肠外医疗营养品市场的市场份额分析

第7章 ：全球肠内和肠外医疗营养市场 - 收入和预测到2028年 - 按适应症分类

  • 概述
  • 肠内和肠外医疗营养市场收入份额，按适应症划分2022年和2028年（%）。
  • 老年人
  • 胃肠道疾病
  • 糖尿病
  • 癌症
  • 呼吸系统疾病
  • 阿尔茨海默氏病
  • 痴呆症
  • 肾脏疾病
  • 肝衰竭
  • COVID-19后
  • 其他适应症

第八章：全球肠内和肠外医疗营养市场 - 收入和预测到2028年 - 按营养类型划分

  • 概述
  • 肠内和肠外医疗营养市场收入份额，按营养类型划分2022年和2028年（%）。
  • 补充型
  • 单一来源

第九章：全球肠内和肠外医疗营养品市场 - 收入和预测到2028年 - 按形式划分

  • 概述
  • 肠内和肠外医疗营养市场收入份额，按形式划分 2022 & 2028 (%)
  • 液体
  • 粉末
  • 半固体

第十章：全球肠内和肠外医疗营养品市场 - 收入和预测到2028年 - 按产品类型划分

  • 概述
  • 2022年和2028年按产品类型分類的肠内和肠外医疗营养品市场收入份额（%）。
  • 一般
  • 特异性疾病

第11章 ：全球肠内和肠外医疗营养市场 - 收入和预测到2028年 - 按给药途径划分

  • 概况
  • 2022年和2028年按给药途径分類的肠内和肠外医疗营养市场收入份额(%)
  • 口服
  • 管饲
  • 肠外

第12章 ：全球肠内和肠外医疗营养市场 - 收入和预测到2028年 - 按年龄组划分

  • 概览
  • 2022年和2028年按年龄组分類的肠内和肠外医疗营养市场收入份额（%）。
  • 60岁以上
  • 18-60岁
  • 3-18岁
  • 3岁以下

第13章 ：全球肠内和肠外医疗营养品市场 - 收入和预测到2028年 - 按分销渠道划分

  • 概览
  • 2022年和2028年按分销渠道分類的肠内和肠外医疗营养品市场收入份额（%）。
  • 医院药房
  • 零售店
  • 电子商务
  • 其他渠道

第十四章：肠内和肠外医疗营养品市场 - 收入和预测到2028年 - 地域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
Product Code: TIPRE00029916

The enteral and parenteral medical nutrition market size is expected to grow from US$ 17.34 billion in 2022 to US$ 25.47 billion by 2028; it is estimated to record a CAGR of 6.8% from 2023 to 2028.

The enteral and parenteral medical nutrition market growth is attributed to the rise in the prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the enteral and parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macro and micronutrient formulations of enteral and parenteral nutrition and its applications vary based on various diseases, such as cancer and gastrointestinal diseases. Moreover, pharmaceutical companies provide enteral and parenteral nutrition with individualized (patient-specific) constituents. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing patients undergoing major elective surgeries to reduce postoperative complications and hospital stay duration and improve clinical outcomes. Efforts of companies for offering such formulations for unique need will propel the growth of the enteral and parenteral medical nutrition market.

Additionally, various organizations are making efforts to spread awareness of the use of specific nutritional formulations. For instance, the American Society for Parenteral and Enteral Nutrition (called ASPEN) is a US-based medical professional organization that employs dietitians, pharmacists, physicians and assistants, nurses, nurse practitioners, scientists, students, and other health professionals from every field of nutrition to provide clinical nutrition to patients and educate them. Such factors will support the enteral and parenteral medical nutrition market growth in the future.

Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are more likely to show intolerance to artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. Thus, the fewer ingredients, the better the final product. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. According to Abbott, consumers and patients relying on tube feeding are no exception to this trend. The American Medical Association is calling on healthcare facilities to propose plant-based meal options to improve patients' health. States including California, New York, and the District of Columbia have asked hospitals to make healthy, plant-based meals available to all patients. Companies in the enteral and parenteral medical nutrition market anticipate that a growing focus on healthy foods would translate into a preference for healthier nutrition products. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults. Similarly, olive oil-based parenteral nutrition products are also gaining popularity.

Therefore, functional, and patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral and parenteral medical nutrition market.

Age Group -Based Insights

Based on age group, the enteral and parenteral medical nutrition market is categorized into above 60 years, 18-60 years, 3-18 years, and below 3 years. In 2022, the above 60 years segment accounted for the largest share in enteral and parenteral medical nutrition market. However, the 18-60 years segment is anticipated to register the highest CAGR during the forecast period. Weight loss and malnutrition are common in people aged above 60 years. With increasing age, the immunity of the older population decreases, and they become more prone to diseases that may deteriorate their health. Due to this, doctors prescribe external nutrition to maintain immunity and weight. According to several studies published in PubMed Central, the prevalence of chronic diseases and disabilities is significantly higher among geriatric people, generating the need for home-based treatments. Also, as per the Population Reference Bureau (2019), it is estimated that the senior population of the US is expected to grow from 52 million in 2018 to 95 million by 2060. The need for home therapy has increased due to the growing demand for home care owing to disability among old age groups. Thus, the increasing geriatric population base is expected to promote the growth of segment in the enteral and parenteral medical nutrition market.

The British Association for Parenteral and Enteral Nutrition, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the enteral and parenteral medical nutrition market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the enteral and parenteral medical nutrition market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global enteral and parenteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Enteral and Parenteral Medical Nutrition Market - By Indication
    • 1.3.2 Global Enteral and Parenteral Medical Nutrition Market - By Nutrition Type
    • 1.3.3 Global Enteral and Parenteral Medical Nutrition Market - By Form
    • 1.3.4 Global Enteral and Parenteral Medical Nutrition Market - By Product Type
    • 1.3.5 Global Enteral and Parenteral Medical Nutrition Market - By Route of Administration
    • 1.3.6 Global Enteral and Parenteral Medical Nutrition Market - By Age Group
    • 1.3.7 Global Enteral and Parenteral Medical Nutrition Market - By Distribution Channel
    • 1.3.8 Global Enteral and Parenteral Medical Nutrition Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Enteral and Parenteral Medical Nutrition Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South And Central America PEST Analysis
  • 4.3 Experts Opinion
  • 4.4 Energy Content Analysis
    • 4.4.1 Lower than 1.5 kcal/ml
    • 4.4.2 Equals to 1.5 kcal/ml
    • 4.4.3 Lower than 2kcal/ml:
    • 4.4.4 Equal to or Higher than 2kcal/ml:

5. Enteral and Parenteral Medical Nutrition Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Gastrointestinal Diseases
    • 5.1.2 Increasing Cases of Malnutrition and Premature Births
  • 5.2 Market Restraints
    • 5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Enteral and Parenteral Feeding Systems, and Limitations Related to Catheter Placement
  • 5.3 Market Opportunities
    • 5.3.1 Growing Strategic Initiatives by Companies
  • 5.4 Future Trends
    • 5.4.1 Specific Formulations and Plant-Based Nutrition Products
  • 5.5 Impact Analysis

6. Enteral and Parenteral Medical Nutrition Market - Global Analysis

  • 6.1 Global Enteral and Parenteral Medical Nutrition Market Revenue Forecast and Analysis
    • 6.1.1 Global Enteral and Parenteral Medical Nutrition Market, By Geography - Forecast and Analysis
  • 6.2 Company Analysis
    • 6.2.1 Market Positioning of Key Players
  • 6.3 Market Share Analysis of Enteral and Parenteral Medical Nutrition Market

7. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Indication

  • 7.1 Overview
  • 7.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
    • 7.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
  • 7.3 Elderly
    • 7.3.1 Overview
    • 7.3.2 Elderly: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
  • 7.4 Gastrointestinal Disorders
    • 7.4.1 Overview
    • 7.4.2 Gastrointestinal Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
    • 7.4.3 Inflammatory Bowel Disease
      • 7.4.3.1 Overview
      • 7.4.3.2 IBD: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.3.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
    • 7.4.4 Irritable Bowel Syndrome
      • 7.4.4.1 Overview
      • 7.4.4.2 IBS: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.4.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
    • 7.4.6 Others
      • 7.4.6.1 Overview
      • 7.4.6.2 Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.6.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
  • 7.5 Diabetes
    • 7.5.1 Overview
    • 7.5.2 Diabetes: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.1.1 Global: Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
  • 7.6 Cancer
    • 7.6.1 Overview
    • 7.6.2 Cancer: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
  • 7.7 Respiratory Disorders
    • 7.7.1 Overview
    • 7.7.2 Respiratory Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.7.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form, 2020-2028 (US$ Million)
  • 7.8 Alzheimer's Disease
    • 7.8.1 Overview
    • 7.8.2 Alzheimer's Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form, 2020-2028 (US$ Million)
  • 7.9 Dementia
    • 7.9.1 Overview
    • 7.9.2 Dementia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.9.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
  • 7.10 Renal Disease
    • 7.10.1 Overview
    • 7.10.2 Renal Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.10.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
  • 7.11 Liver Failure
    • 7.11.1 Overview
    • 7.11.2 Liver Failure: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.11.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
  • 7.12 Post COVID-19
    • 7.12.1 Overview
    • 7.12.2 Post COVID-19: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.12.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
  • 7.13 Other Indications
    • 7.13.1 Overview
    • 7.13.2 Other Indications: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.13.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)

8. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Nutrition Type

  • 8.1 Overview
  • 8.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
    • 8.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
  • 8.3 Supplemental
    • 8.3.1 Overview
    • 8.3.2 Supplemental: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Sole-Source
    • 8.4.1 Overview
    • 8.4.2 Sole-Source: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Form

  • 9.1 Overview
  • 9.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
    • 9.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
  • 9.3 Liquid
    • 9.3.1 Overview
    • 9.3.2 Liquid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Powder
    • 9.4.1 Overview
    • 9.4.2 Powder: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Semi-Solid
    • 9.5.1 Overview
    • 9.5.2 Semi-Solid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

10. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Product Type

  • 10.1 Overview
  • 10.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
    • 10.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
  • 10.3 General
    • 10.3.1 Overview
    • 10.3.2 General: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Disease-Specific
    • 10.4.1 Overview
    • 10.4.2 Disease-Specific: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

11. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Route of Administration

  • 11.1 Overview
  • 11.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
    • 11.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
  • 11.3 Oral
    • 11.3.1 Overview
    • 11.3.2 Oral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Tube Feed
    • 11.4.1 Overview
    • 11.4.2 Tube Feed: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Parenteral
    • 11.5.1 Overview
    • 11.5.2 Parenteral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

12. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Age Group

  • 12.1 Overview
  • 12.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
    • 12.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
  • 12.3 Above 60 Years
    • 12.3.1 Overview
    • 12.3.2 Above 60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.4 18-60 Years
    • 12.4.1 Overview
    • 12.4.2 18-60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.5 3-18 Years
    • 12.5.1 Overview
    • 12.5.2 3-18 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.6 Below 3 Years
    • 12.6.1 Overview
    • 12.6.2 Below 3 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

13. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Distribution Channel

  • 13.1 Overview
  • 13.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
    • 13.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
  • 13.3 Hospital Pharmacies
    • 13.3.1 Overview
    • 13.3.2 Hospital Pharmacies: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.4 Retail Stores
    • 13.4.1 Overview
    • 13.4.2 Retail Stores: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.5 E-Commerce
    • 13.5.1 Overview
    • 13.5.2 E-Commerce: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.6 Others
    • 13.6.1 Overview
    • 13.6.2 Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

14. Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 14.1 North America: Enteral and Parenteral Medical Nutrition Market
    • 14.1.9.1 US: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.1.9.2 Canada: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 14.2 Europe: Enteral and Parenteral Medical Nutrition Market
    • 14.2.1 Overview
    • 14.2.10.1 Germany: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.2 UK: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.3 France: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.4 Italy: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.5 Spain: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.6 Netherlands: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.7 Switzerland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.8 Poland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.9 Sweden: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.10 Belgium: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.11 Rest of Europe: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
  • 14.3 Asia Pacific: Enteral and Parenteral Medical Nutrition Market
    • 14.3.1 Overview
    • 14.3.9.1 China: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.1.1 Overview
    • 14.3.9.2 Japan: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.3 India: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.4 Australia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.5 South Korea: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.6 Indonesia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.7 Thailand: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.8 Vietnam: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.9 Rest of Asia Pacific: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
  • 14.4 Middle East & Africa Enteral and Parenteral Medical Nutrition Market
    • 14.4.1 Overview
    • 14.4.9.1 Saudi Arabia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.2 South Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.3 UAE: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.4 Iran: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.5 Israel: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.6 Egypt: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.7 Rest of Middle East & Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
  • 14.5 South & Central America Enteral and Parenteral Medical Nutrition Market
    • 14.5.1 Overview
    • 14.5.10.1 Mexico: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.2 Brazil: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.3 Argentina: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.4 Chile: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.5 Peru: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.6 Colombia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.7 Rest of South & Central America: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)

    15. Impact Of COVID-19 Pandemic on Enteral and Parenteral Medical Nutrition Market

    • 15.1 North America: Impact Assessment of COVID-19 Pandemic
    • 15.2 Europe: Impact Assessment of COVID-19 Pandemic
    • 15.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
    • 15.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
    • 15.5 South & Central America: Impact Assessment of COVID-19 Pandemic

    16. Enteral and Parenteral Medical Nutrition Market – Industry Landscape

    • 16.1 Overview
    • 16.2 Growth Strategies in the Enteral and Parenteral Medical Nutrition Market
    • 16.3 Inorganic Growth Strategies
    • 16.3.1 Overview
    • 16.4 Organic Growth Strategies
    • 16.4.1 Overview

    17. Company Profiles

    • 17.1 Abbott Laboratories
      • 17.1.1 Key Facts
      • 17.1.2 Business Description
      • 17.1.3 Products and Services
      • 17.1.4 Financial Overview
      • 17.1.5 SWOT Analysis
      • 17.1.6 Key Developments
    • 17.2 Nestle SA
      • 17.2.1 Key Facts
      • 17.2.2 Business Description
      • 17.2.3 Products and Services
      • 17.2.4 Financial Overview
      • 17.2.5 SWOT Analysis
      • 17.2.6 Key Developments
    • 17.3 Nutricia International BV
      • 17.3.1 Key Facts
      • 17.3.2 Business Description
      • 17.3.3 Products and Services
      • 17.3.4 Financial Overview
      • 17.3.5 SWOT Analysis
      • 17.3.6 Key Developments
    • 17.4 Medtrition Inc
      • 17.4.1 Key Facts
      • 17.4.2 Business Description
      • 17.4.3 Products and Services
      • 17.4.4 Financial Overview
      • 17.4.5 SWOT Analysis
      • 17.4.6 Key Developments
    • 17.5 Fresenius Kabi AG
      • 17.5.1 Key Facts
      • 17.5.2 Business Description
      • 17.5.3 Products and Services
      • 17.5.4 Financial Overview
      • 17.5.5 SWOT Analysis
      • 17.5.6 Key Developments
    • 17.6 B. Braun SE
      • 17.6.1 Key Facts
      • 17.6.2 Business Description
      • 17.6.3 Products and Services
      • 17.6.4 Financial Overview
      • 17.6.5 SWOT Analysis
      • 17.6.6 Key Developments
    • 17.7 Smartfish AS
      • 17.7.1 Key Facts
      • 17.7.2 Business Description
      • 17.7.3 Products and Services
      • 17.7.4 Financial Overview
      • 17.7.5 SWOT Analysis
      • 17.7.6 Key Developments
    • 17.8 Nutrisens SAS
      • 17.8.1 Key Facts
      • 17.8.2 Business Description
      • 17.8.3 Products and Services
      • 17.8.4 Financial Overview
      • 17.8.5 SWOT Analysis
      • 17.8.6 Key Developments
    • 17.9 AYMES International Ltd
      • 17.9.1 Key Facts
      • 17.9.2 Business Description
      • 17.9.3 Products and Services
      • 17.9.4 Financial Overview
      • 17.9.5 SWOT Analysis
      • 17.9.6 Key Developments
    • 17.10 Medifood International SA
      • 17.10.1 Key Facts
      • 17.10.2 Business Description
      • 17.10.3 Products and Services
      • 17.10.4 Financial Overview
      • 17.10.5 SWOT Analysis
      • 17.10.6 Key Developments
    • 17.11 Easy Line Ltd
      • 17.11.1 Key Facts
      • 17.11.2 Business Description
      • 17.11.3 Products and Services
      • 17.11.4 Financial Overview
      • 17.11.5 SWOT Analysis
      • 17.11.6 Key Developments
    • 17.12 Charing Cross Scientific AS
      • 17.12.1 Key Facts
      • 17.12.2 Business Description
      • 17.12.3 Products and Services
      • 17.12.4 Financial Overview
      • 17.12.5 SWOT Analysis
      • 17.12.6 Key Developments
    • 17.13 Baxter International Inc
      • 17.13.1 Key Facts
      • 17.13.2 Business Description
      • 17.13.3 Products and Services
      • 17.13.4 Financial Overview
      • 17.13.5 SWOT Analysis
      • 17.13.6 Key Developments
    • 17.14 Medica Nutrition Inc
      • 17.14.1 Key Facts
      • 17.14.2 Business Description
      • 17.14.3 Products and Services
      • 17.14.4 Financial Overview
      • 17.14.5 SWOT Analysis
      • 17.14.6 Key Developments

    18. Appendix

    • 18.1 About The Insight Partners
    • 18.2 Glossary of Terms

List Of Tables

List Of Figures

  • Figure 1. Enteral and Parenteral Medical Nutrition Market Segmentation
  • Figure 2. Enteral and Parenteral Medical Nutrition Market, By Region
  • Figure 3. Global Enteral and Parenteral Medical Nutrition Market Overview
  • Figure 4. Elderly Segment Held Largest Share of Indication Segment in Enteral and Parenteral Medical Nutrition Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Enteral and Parenteral Medical Nutrition Market, by Geography (US$ Million)
  • Figure 7. Global Enteral and Parenteral Medical Nutrition Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Enteral and Parenteral Medical Nutrition Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South And Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Impact Analysis
  • Figure 16. Global Enteral and Parenteral Medical Nutrition Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Enteral and Parenteral Medical Nutrition Market- By Geography Forecast and Analysis - 2022 & 2028
  • Figure 18. Market Positioning of Key Players in Enteral and Parenteral Medical Nutrition Market
  • Figure 19. Market Share Analysis of Key Players in Enteral and Parenteral Medical Nutrition Market (2022)
  • Figure 20. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
  • Figure 21. Elderly: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Gastrointestinal Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. IBD: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. IBS: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Diabetes: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Cancer: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Respiratory Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Alzheimer's Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Dementia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Renal Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Liver Failure: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Post COVID-19: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Other Indications: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
  • Figure 36. Supplemental: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Sole Source: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
  • Figure 39. Liquid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Powder: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Semi-Solid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
  • Figure 43. General: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Disease Specific: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
  • Figure 46. Oral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Tube Feed: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Parenteral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
  • Figure 50. Above 60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. 18-60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. 3-18 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Below 3 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
  • Figure 55. Hospital Pharmacies: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. Retail Stores: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. E-Commerce: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. North America: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 60. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. North America: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 62. US: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Canada: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Europe: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 65. Europe Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. Europe: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 67. Germany: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. UK: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. France: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Italy: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Spain: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 72. Netherlands: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 73. Switzerland: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 74. Poland: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 75. Sweden: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 76. Belgium: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 77. Rest of Europe: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 78. Asia Pacific: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 79. Asia Pacific Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 80. Asia Pacific: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 81. China: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 82. Japan: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 83. India: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 84. Australia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 85. South Korea: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 86. Indonesia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 87. Thailand: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 88. Vietnam: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 89. Rest of Asia Pacific: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 90. Middle East & Africa: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 91. Middle East & Africa Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 92. Middle East & Africa: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 93. Saudi Arabia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 94. South Africa: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 95. UAE: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 96. Iran: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 97. Israel: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 98. Egypt: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 99. Rest of Middle East & Africa: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 100. South & Central America: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 101. South & Central America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 102. South & Central America: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 103. Mexico: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 104. Brazil: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 105. Argentina: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 106. Chile: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 107. Peru: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 108. Colombia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 109. Rest of South & Central America: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 110. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 111. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 112. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 113. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 114. Impact of COVID-19 Pandemic on South & Central American Country Markets
  • Figure 115. Growth Strategies in the Enteral and Parenteral Medical Nutrition Market